COVID-19

COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease?

2022

Authors: Donà D, Montagnani C, Di Chiara C, Venturini E, Galli L, Lo Vecchio A, Denina M, Olivini N, Bruzzese E, Campana A, Giacchero R, Salvini F, Meini A, Ponzoni M, Trapani S, Rossi E, Lombardi MH, Badolato R, Pierri L, Pruccoli G, Rossin S, Colomba C, Cazzato S, Pacati I, Nicolini G, Pierantoni L, Bianchini S, Krzysztofiak A, Garazzino S, Giaquinto C, Castelli Gattinara G

Published in: Viruses

Symptom presentation among SARS-CoV-2 positive cases and the impact of COVID-19 vaccination; three prospective household cohorts

2022

Authors: Westerhof I, De Hoog M, Ieven M, Lammens C, Van Beek J, Rozhnova G, Eggink D, Euser S, Wildenbeest J, Duijts L, Van Houten M, Goossens H, Giaquinto C, Bruijning-Verhagen P.

Published in: MedRxiv

Controlling SARS-CoV-2 in schools using repetitive testing strategies

2022

Authors: Torneri A, Willem L, Colizza V, Kremer C, Meuris C, Darcis G, Hens N, Libin PJK.

Published in: eLife

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age

2022

Authors: Cohen-Stavi CJ, Magen O, Barda N, Yaron S, Peretz A, Netzer D, Giaquinto C, Judd A, Leibovici L, Hernán MA, Lipsitch M, Reis BY, Balicer RD, Dagan N.

Published in: The New England Journal of Medicine

Seasonal patterns of SARS-CoV-2 transmission in secondary schools: a modelling study

2022

Authors: Pham TM, Westerhof I, Bootsma MCJ, Kretzschmar ME, Rozhnova G, Bruijning-Verhagen P.

Published in: MedRxiv

Omicron Neutralizing and Anti-SARS-CoV-2 S-RBD Antibodies in Naïve and Convalescent Populations After Homologous and Heterologous Boosting With an mRNA Vaccine

2022

Authors: Pagliari M, Mazzetto E, Gastaldelli M, Bortolami A, Donà D, Padoan A, Di Chiara C, Pezzani MD, Cosma C, Napolitan A, Quaranta EG, Giussani E, Fusaro A, Pascarella M, Aita A, Liberati C, Lorusso A, Monne I, De Rossi A, Basso D, Porru S, Ricci A, Terregino C, Plebani M, Tacconelli E*, Giaquinto C*, Bonfante F*.

Published in: Lancet Preprints

Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild COVID-19 in Children

2022

Authors: C. D. Chiara, S. Carraro, S. Zanconato, S. Cozzani, E. Baraldi et al.

Published in: National Library of Medicine

Early Use of Sotrovimab in Children:A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

2022

Authors: Di Chiara C, Mengato D, De Pieri M, Longo G, Benetti E, Venturini F, Giaquinto C and Donà D.

Published in: Children

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease

2022

Authors: L. Bosa, C. Di Chiara, P. Gaio, C. Cosma, A. Padoan et al.

Published in: Frontiers in Pediatrics

Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022

2022

Authors: Colosi E, Bassignana G, Barrat A, Lina B, Vanhems P, Bielicki J, Colizza V.

Published in: MedRxiv

Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection

2021

Authors: D Sirico, CD Chiara, P Costenaro, F Bonfante, S Cozzani, M Plebani, E Reffo, B Castaldi, D Dona, LD Dalt, C Giaquinto, and GD Salvo

Published in: European Heart Journal

 

Abstract

Aims Compared with adult patients, clinical manifestations of children’s coronavirus disease-2019 (COVID-19) are generally perceived as less severe.

Mild SARS-CoV-2 infections and neutralizing antibody titers

2021

Authors: F Bonfante, P Costenaro, A Cantarutti, CD Chiara, A Bortolami, MR Petrara, F Carmona, M Pagliari, C Cosma, S Cozzani, E Mazzetto, GD Salvo, LD Dalt, P Palma, L Barzon, G Corrao, C Terregino, A Padoan, M Plebani, AD Rossi, D Donà, C Giaquinto

Published in: Pediatrics

 

Abstract

Background. Recent evidence suggests that neutralizing antibodies to SARS-CoV-2 may persist over time;

1